Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0149782
Disease: Squamous cell carcinoma of lung
Squamous cell carcinoma of lung
0.300 GeneticVariation disease UNIPROT
CUI: C0349637
Disease: Common acute lymphoblastic leukemia
Common acute lymphoblastic leukemia
0.010 Biomarker disease BEFREE The common acute lymphoblastic leukemia antigen (CALLA) is a 749-amino acid type II integral membrane protein that has been identified recently as the neutral endopeptidase 24.11 [NEP (EC 3.4.24.11)]. 2528730 1989
CUI: C0017638
Disease: Glioma
Glioma
0.020 AlteredExpression disease BEFREE In the present study, we investigated whether cALLa expressed on glioma cell lines is active NEP. 2531122 1989
CUI: C0023418
Disease: leukemia
leukemia
0.010 AlteredExpression disease BEFREE The amino acid sequence of cALLa is identical to that of neutral endopeptidase (NEP,E.C.3.4.24.11), and cALLa expressed on leukemia and melanoma cell lines is enzymatically active NEP. 2531122 1989
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.010 AlteredExpression disease BEFREE The amino acid sequence of cALLa is identical to that of neutral endopeptidase (NEP,E.C.3.4.24.11), and cALLa expressed on leukemia and melanoma cell lines is enzymatically active NEP. 2531122 1989
CUI: C4721610
Disease: Carcinoma, Ovarian Epithelial
Carcinoma, Ovarian Epithelial
0.040 Biomarker disease BEFREE A protein receptor tyrosine kinase (EDDR1) has been isolated from a complementary DNA library of SKOV-3, an epithelial ovarian cancer cell line. 7789998 1995
CUI: C0677886
Disease: Epithelial ovarian cancer
Epithelial ovarian cancer
0.030 Biomarker disease BEFREE A protein receptor tyrosine kinase (EDDR1) has been isolated from a complementary DNA library of SKOV-3, an epithelial ovarian cancer cell line. 7789998 1995
CUI: C4721610
Disease: Carcinoma, Ovarian Epithelial
Carcinoma, Ovarian Epithelial
0.040 Biomarker disease BEFREE A protein receptor tyrosine kinase (RTK 6) has been isolated from a complementary DNA library of SKOV-3, an epithelial ovarian cancer cell line, using a polymerase chain reaction (PCR)-mediated approach. 7848919 1994
CUI: C0677886
Disease: Epithelial ovarian cancer
Epithelial ovarian cancer
0.030 Biomarker disease BEFREE A protein receptor tyrosine kinase (RTK 6) has been isolated from a complementary DNA library of SKOV-3, an epithelial ovarian cancer cell line, using a polymerase chain reaction (PCR)-mediated approach. 7848919 1994
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.040 AlteredExpression group BEFREE Identification of two isoforms of the Cak receptor kinase that are coexpressed in breast tumor cell lines. 8622863 1996
Malignant neoplasm of urinary bladder
0.020 AlteredExpression disease BEFREE The results indicated that TRK-E and Arg kinases were more abundantly expressed than several other kinases in bladder cancer. 9252693 1997
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm
0.020 AlteredExpression disease BEFREE The results indicated that TRK-E and Arg kinases were more abundantly expressed than several other kinases in bladder cancer. 9252693 1997
CUI: C0699885
Disease: Carcinoma of bladder
Carcinoma of bladder
0.020 AlteredExpression disease BEFREE The results indicated that TRK-E and Arg kinases were more abundantly expressed than several other kinases in bladder cancer. 9252693 1997
androgen independent prostate cancer
0.010 Biomarker disease BEFREE Methylation of the NEP promoter was present in androgen-independent PC cell lines but not in androgen-dependent or small-cell derived PC cell lines and in 3 of 21 (14%) primary PCs from patients with androgen-dependent disease. 10815884 2000
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 AlteredExpression group BEFREE All the high-grade primary brain and metastatic brain tumors showed unequivocal, intense DDR1 expression within the majority of tumor cells, whereas expression was not observed in hyperplastic tumor blood vessels, normal brain blood vessels, inflammatory cells, or in the normal brain tissue that surrounded the tumor. 11126911 2000
CUI: C0017636
Disease: Glioblastoma
Glioblastoma
0.040 AlteredExpression disease BEFREE By use of a digoxigenin-labeled DDR1 riboprobe, we investigated the expression of DDR1 messenger ribonucleic acid in a prospective series of 30 resected human primary and metastatic brain neoplasms, nonneoplastic human brain, and mouse embryonic brain, as well as a mouse glioblastoma model, by in situ hybridization. 11126911 2000
CUI: C1621958
Disease: Glioblastoma Multiforme
Glioblastoma Multiforme
0.040 AlteredExpression disease BEFREE By use of a digoxigenin-labeled DDR1 riboprobe, we investigated the expression of DDR1 messenger ribonucleic acid in a prospective series of 30 resected human primary and metastatic brain neoplasms, nonneoplastic human brain, and mouse embryonic brain, as well as a mouse glioblastoma model, by in situ hybridization. 11126911 2000
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.030 AlteredExpression disease BEFREE By use of a digoxigenin-labeled DDR1 riboprobe, we investigated the expression of DDR1 messenger ribonucleic acid in a prospective series of 30 resected human primary and metastatic brain neoplasms, nonneoplastic human brain, and mouse embryonic brain, as well as a mouse glioblastoma model, by in situ hybridization. 11126911 2000
CUI: C0280474
Disease: Childhood Glioblastoma
Childhood Glioblastoma
0.030 AlteredExpression disease BEFREE By use of a digoxigenin-labeled DDR1 riboprobe, we investigated the expression of DDR1 messenger ribonucleic acid in a prospective series of 30 resected human primary and metastatic brain neoplasms, nonneoplastic human brain, and mouse embryonic brain, as well as a mouse glioblastoma model, by in situ hybridization. 11126911 2000
CUI: C0006118
Disease: Brain Neoplasms
Brain Neoplasms
0.010 AlteredExpression group BEFREE By use of a digoxigenin-labeled DDR1 riboprobe, we investigated the expression of DDR1 messenger ribonucleic acid in a prospective series of 30 resected human primary and metastatic brain neoplasms, nonneoplastic human brain, and mouse embryonic brain, as well as a mouse glioblastoma model, by in situ hybridization. 11126911 2000
CUI: C0085136
Disease: Central Nervous System Neoplasms
Central Nervous System Neoplasms
0.010 Biomarker group BEFREE The expression of DDR1 by tumor cells of CNS neoplasms and by primitive cells of the embryonic ventricular zone suggests that DDR1 is a potentially useful marker of tumor cells within the CNS. 11126911 2000
CUI: C0018801
Disease: Heart failure
Heart failure
0.210 AlteredExpression disease BEFREE Methods and Results- NEP mRNA was quantitated by real-time polymerase chain reaction (PCR) in left ventricular biopsies from patients with aortic valve stenosis (AS, n=19) and heart failure due to dilated cardiomyopathy (DCM, n=14), and control subjects with normal systolic function (CON, n=14). 11804980 2002
CUI: C0018802
Disease: Congestive heart failure
Congestive heart failure
0.210 AlteredExpression disease BEFREE Methods and Results- NEP mRNA was quantitated by real-time polymerase chain reaction (PCR) in left ventricular biopsies from patients with aortic valve stenosis (AS, n=19) and heart failure due to dilated cardiomyopathy (DCM, n=14), and control subjects with normal systolic function (CON, n=14). 11804980 2002
CUI: C0003507
Disease: Aortic Valve Stenosis
Aortic Valve Stenosis
0.010 AlteredExpression disease BEFREE Methods and Results- NEP mRNA was quantitated by real-time polymerase chain reaction (PCR) in left ventricular biopsies from patients with aortic valve stenosis (AS, n=19) and heart failure due to dilated cardiomyopathy (DCM, n=14), and control subjects with normal systolic function (CON, n=14). 11804980 2002
CUI: C0007193
Disease: Cardiomyopathy, Dilated
Cardiomyopathy, Dilated
0.010 AlteredExpression group BEFREE Methods and Results- NEP mRNA was quantitated by real-time polymerase chain reaction (PCR) in left ventricular biopsies from patients with aortic valve stenosis (AS, n=19) and heart failure due to dilated cardiomyopathy (DCM, n=14), and control subjects with normal systolic function (CON, n=14). 11804980 2002